HAJA DUMBUYA: Open Payments
NPI 1861951816 · OREGON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,634 in 123 payments from 22 companies in 2025. Trend: 2023 $224 · 2024 $1,687 · 2025 $2,634
Food & beverage: $2,634
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $661 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $311 |
| Ardelyx, Inc. | 9 | $199 |
| Janssen Biotech, Inc. | 10 | $194 |
| QOL Medical, LLC | 8 | $192 |
| Regeneron Healthcare Solutions, Inc. | 6 | $140 |
| Celltrion USA Inc. | 6 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $118 |
| Madrigal Pharmaceuticals | 5 | $106 |
| Ipsen Biopharmaceuticals, Inc | 5 | $102 |
Products named: RINVOQ, ENTYVIO, SKYRIZI, IBSRELA, TREMFYA, Sucraid, DUPIXENT, VEGZELMA.
Industry payments across OH — which companies pay providers there.
